Skip to main content
. 2015 Feb 9;10(2):e0117044. doi: 10.1371/journal.pone.0117044

Table 1. General clinical characteristics of the Chinese population with positive or negative history of diabetes (adjusted for age and gender).

  FH0 FH1 FH2 P-value
FH1 vs FH0 FH2 vs FH0 FH1 vs FH2
Number 30,195 5443 643
Gender (M/F) 11,951/18,244 2072/3371 240/403
Prevalence of DM (%) 8.4 20.1 32.7 <0.0001 <0.0001 0.0003
7.9, 8.9 18.2, 22.1 26.4, 39.7
Age (years) 44.9 44.9 45.1 0.2834 0.1876 0.3892
44.8, 44.9 44.8, 45.1 44.7, 45.5
Age of diagnosis of DM (years) 45.3 43.9 44.6 0.0002 0.0409 0.2035
45.1, 45.4 43.2, 44.6 43.9, 45.2
Maximal weight (kg) 65.3 69.2 71.0 <0.0001 <0.0001 0.0075
65.1, 65.6 68.6, 69.8 69.9, 72.2
Smoking (%) 24.8 25.6 29.1 0.4312 0.1609 0.2841
23.9, 25.6 23.7, 27.7 23.5, 35.5
Drinking (%) 21.3 26.2 28.6 <0.0001 0.0171 0.4480
20.5, 22.1 24.3, 28.1 23.0, 34.9
Central obesity (%) 27.40 34.00 41.7000 <0.0001 <0.0001 0.0148
26.6, 28.3 31.8, 36.4 36.1, 47.5
Body mass index (kg/m2) 23.85 24.54 25.11 <0.0001 <0.0001 0.0204
23.78, 23.92 24.34, 24.74 24.67, 25.56
Systolic blood pressure (mmHg) 122.7 123.9 123.8 0.0158 0.2598 0.9289
122.4, 123.1 123.0, 124.7 122.0, 125.6
Diastolic blood pressure (mmHg) 77.8 78.6 80.6 0.0100 <0.0001 0.0039
77.6, 78.1 78.1, 79.2 79.4, 81.8
FPG (mmol/L) 5.2 5.8 6.5 <0.0001 <0.0001 0.0005
5.2, 5.2 5.6, 6.0 6.2, 6.8
PG2h (mmol/L) 6.8 8.1 9.6 <0.0001 <0.0001 0.0001
6.8, 6.9 7.8, 8.4 8.9, 10.2
FINS (mU/L)* 6.9 7.7 7.3 0.0006 0.0238 0.6814
5.0, 9.6 5.5, 10.7 5.1, 10.7
INS2h (mU/L)* 25.4 31.2 34.6 <0.0001 0.0006 0.8351
15.2, 43.3 18.6, 54.9 19.0, 56.9
TCHO (mmol/L)* 4.66 4.74 5.00 0.0024 <0.0001 0.0015
4.03, 5.34 4.18, 5.37 4.42, 5.52
TG (mmol/L)* 1.21 1.39 1.64 <0.0001 0.0004 0.2556
0.85, 1.82 0.94, 2.07 0.98, 2.24
LDLC (mmol/L)* 2.54 2.75 3.11 <0.0001 <0.0001 0.1305
2.04, 3.09 2.28, 3.29 2.52, 3.37
HDLC (mmol/L)* 1.25 1.25 1.25 0.4728 0.9045 0.8669
1.07, 1.48 1.06, 1.48 1.05, 1.53
ΔI30/ΔG30a,* 8.28 7.75 5.97 0.0132 0.8311 0.2763
4.39, 15.50 3.91, 14.92 4.03, 12.53
CIR* 750.8 688.2 461.9 0.0001 <0.0001 0.0039
427.3, 1324.3 375.3, 1261.9 266.1, 954.5
ISI* 136.3 116.9 115.5 <0.0001 <0.0001 0.0107
92.7, 193.9 76.8, 165.6 73.2, 153.2
HOMA-IR* 1.53 1.77 1.86 <0.0001 <0.0001 0.0086
1.08, 2.25 1.22, 2.70 1.40, 2.98
DI30 b,* 1107.6 926.9 580.8 <0.0001 <0.0001 0.4604
606.6,1888.3 450.9, 1654.6 397.4, 1296.9
DI c ,* (×103) 104.1 84.1 48.5 <0.0001 <0.0001 0.0001
60.7, 167.8 44.4, 142.9 24.2, 94.4      

Note: Variables with asterisk (*) are presented as the range of median to quartile, and other variables are presented as the mean with 95% CI.

a ΔI30/ΔG30 = (INS30 - FINS)/(PG30 - FPG).

b DI30 = ΔI30/ΔG30 × ISI.

c DI = CIR × ISI.

ISI = 10,000/√(fasting plasma glucose [mmol/L] × fasting insulin [mU/L]) × (mean OGTT glucose [mmol/L] × mean OGTT insulin [mU/L]).

CI: confidence interval; CIR: corrected insulin response; DI: disposition index; DM: diabetes mellitus; FH0: negative family history of diabetes; FH1: moderate family history risk category of diabetes; FH2: high family history risk category of diabetes. FINS: fasting plasma insulin; FPG: fasting plasma glucose; HDLC: high-density lipoprotein cholesterol; HOMA-IR: homeostatic model assessment-estimated insulin resistance; INS2h: 2-h postload plasma insulin; INS30: serum insulin level at 30 min after OGTT; ISI: insulin sensitivity index; LDLC: low-density lipoprotein cholesterol; OGTT: oral glucose tolerance test; PG2h: 2-h postload plasma glucose; PG30: plasma glucose level at 30 min after OGTT; TCHO: total serum cholesterol; TG: serum triglyceride.